Products

PEA Liquid

Palmitoylethanolamide (PEA)

Product Discontinued

This product was discontinued in June 2023. Please contact our helpful team if you have any questions.

99% pure PEA, micronised to a 20um-25um particle size using laser diffraction.

This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional.

(PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators.

Serving Type: Oral Liquid
Available in Sizes: 100mL Dosage: For extemporaneous compounding by a qualified health professional. INFORMATION FOR COMPOUNDING: 2 mL provides 300 mg of palmitoylethanolamide.

Where to buy

This product is not available in your country

Product Features

This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional.

PEA is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators.
PEA Liquid is micronised to a 20um-25um particle size using laser diffraction.
Presented in a coconut-derived (MCT) lipid suspension for ease of compounding.
2mL contains 300mg PEA for easy dose calculation.
Synthesised from palmitic acid from sustainably sourced palm oil, RSPO certified palm oil.
PEA Liquid contains 99% pure PEA, which has been confirmed by purity testing.
Low allergen, clean formula. Pleasant natural orange flavour.

Ingredients

Palmidrol Palmitoylethanolamide

300 mg

Warning

KEEP OUT OF REACH OF CHILDREN.
Compounding preparations should be supplied to an individual only after consultation with a health professional.
It is required that a label is attached to the medicine providing instructions for use for that individual.
Contains ethanol 6% v/v as a preservative.
Do not use if seal on cap is broken.
Shake well before use.